DCs electroporated with mRNA encoding the melanoma-associated antigens tyrosinase or gp100 and TriMix and administered intranasally to patients with advanced melanoma evoked modest antitumor responses, according to the findings of one investigation [253]. The gene discussed is TYR; the disease is melanoma.